This site is intended exclusively for legally qualified professionals.
Free shipping for orders over €150.00 (Italy only)
Aliquota IVA applicata: 22%
NanoBone®
The NanoBone® synthetic material offers dentists a safe material for bone reconstruction. In over 5 years of use in dental practices, with over 100,000 treatments worldwide, NanoBone® has proven its worth. Users have access to a variety of products for specific indications. The NanoBone® synthetic reconstruction material is available in granular or block form. A comprehensive technology – NanoBone® technology – offers a wide range of products that simplify daily work in the dental practice. Long-term studies confirm all the good reasons for choosing NanoBone® .
For daily surgical use, NanoBone® in granular form is available in very small granules (0.6 x 2 mm) or small granules (1 x 2 mm), depending on the indication and the size of the defect. To address various indications with specific products, NanoBone® technology offers granules with differentiated resorption kinetics. NanoBone® in granular form was the first product of NanoBone® technology and was launched on the market in 2005. Those who use it swear by its ease of use. By mixing it with the patient's blood, a paste-like consistency is obtained that can be easily inserted, with appropriate instruments, wherever needed.
Not sintered
All NanoBone® technology products are produced using the sol-gel process at 700°C. This low temperature prevents the material from sintering, resulting in a highly porous surface with pores ranging from nanometers to micrometers in size. Autologous blood proteins penetrate these nanopores, covering their entire internal surface. Our body recognizes NanoBone® as an endogenous element, triggering the natural remodeling process.
Osteoconduction
Harms et al. attribute NanoBone® to a high osteoconductive potential. The augmentation material acts as a guardrail. The formation of a protein-rich organic matrix promotes the ingrowth of connective tissue and blood vessels.
Götz et al. demonstrated the osteoinductive nature of NanoBone® . Attraction and differentiation of osteoblasts and osteoclasts could be demonstrated. In animal experiments with Göttingen minipigs, ectopic bone formation was observed.
In addition to bone replacement materials previously available on the market, NanoBone® technology represents a completely new group. Nanocrystalline hydroxyapatite (HA) is embedded in a silica gel ( SiO2 ). This nanocrystalline hydroxyapatite approximately corresponds to that found in autologous bone. The silica gel promotes collagen and bone formation.
Produced using the sol-gel process at temperatures up to 700°C, the material is not sintered and features pores ranging from nanometers to micrometers in size. The potential of nanotechnology is exploited with HA nanocrystals and interconnecting nanopores. Blood proteins cover the entire internal surface (approximately 84 m²/g), and the body recognizes the biomaterial almost as if it were an endogenous element.
Within the first two weeks, the silica gel matrix transforms into an organic matrix. Through this process, each NanoBone® granule now corresponds to the extracellular matrix of bone tissue.
NanoBone® promotes natural remodeling. The attraction and differentiation of osteoblasts and osteoclasts strongly suggest the biomaterial's osteoinductive nature.
